Miller, Paul F.
Synlogic (United States)
4 papers on CoChatORCID 0000-0002-7899-6798
Most cited papers
- Verified
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology
Bacterial Cancer TherapyProbiotics and Fermented Foods
Cited by 605
- Verified
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications
Bacterial Cancer TherapyImmunotherapy and Immune Responses
Cited by 458
- Verified
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine
Bacterial Cancer TherapyAmino Acid Enzymes and Metabolism
Cited by 399
- Verified
Translational Development of Microbiome‐Based Therapeutics: Kinetics of E. coli Nissle and Engineered Strains in Humans and Nonhuman Primates
Kurtz, C., Denney, W. S., Blankstein, L., Guilmain, S. E., Machinani, S., Kotula, J., Saha, S., Miller, P., & Brennan, A. M. (2018) · Clinical and Translational Science
Probiotics and Fermented FoodsBacterial Cancer Therapy
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free